Sponsor Pipeline

Pharmacosmos A/S Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
5
Recruiting
3
Phase 3
5
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-08 NCT05179226
Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age With Iron…		 date change Primary completion pushed: 2026-04-30 -> 2027-04-30
2026-08-08 NCT05179226
Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age With Iron…		 date change Completion pushed: 2026-04-30 -> 2027-04-30
Active Trials by Phase
Phase 4
1
Phase 3
3
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT05874401 Trilaciclib vs Placebo in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)… Extensive-stage Small-cell Lung Cancer Recruiting
Phase 3
NCT06929806 Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient… Chronic Heart Failure Recruiting
NCT07473128 Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage… Limited Stage Small Cell Lung Cancer Recruiting
NCT05179226 Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age With Iron… Iron Deficiency, Anaemia in Children Recruiting
Phase 2
NCT05693909 A Trial Testing SP-420 in Subjects With Transfusion-dependent β-thalassemia or Low-risk… Beta Thalassemia Major Anemia Recruiting
Disease Areas
Lung Cancer (2) Myelodysplastic Syndromes (MDS) (1) Thalassemia (1) Heart Failure (1) Small Cell Lung Cancer (1)
Get alerts when Pharmacosmos A/S's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free